Información:
Error:
ID
13255
Descripción
Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS; ODM derived from: https://clinicaltrials.gov/show/NCT00038831
Link
https://clinicaltrials.gov/show/NCT00038831
Palabras clave
Versiones (1)
- 26/1/16 26/1/16 -
Titular de derechos de autor
CC BY-NC 3.0
Subido en
26 de enero de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Acute Myelogenous Leukemia NCT00038831
Eligibility Acute Myelogenous Leukemia NCT00038831
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myelogenous Leukemia NCT00038831
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
age
Item
patients 12-75 years of age
boolean
C0001779 (UMLS CUI [1])
patients are eligible if deemed ineligible for conventional high dose chemotherapy
Item
patients are eligible if deemed ineligible for conventional high dose chemotherapy programs because of concurrent medical conditions. patients with refractory aml are always eligible if ejection fraction > 35, fev1, fvc, or dlco > 40%, abnormal lft's.
boolean
C0392920 (UMLS CUI [1])
toxicity
Item
patients must have recovered from previous grade iii-iv toxicity due to prior anti-neoplastic therapy (except alopecia).
boolean
C0013221 (UMLS CUI [1])
disease categories
Item
patients with the following disease categories will be eligible: 1. aml with induction failure, relapse or 2nd remission 2. mds with ipi int-2 or high-risk disease (appendix 4) or cmml 3. cml in accelerated phase or blast crisis 4. interferon or sti resistant cml not eligible for conventional stem cell transplant
boolean
C0023467 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
C0023474 (UMLS CUI [3])
C3463824 (UMLS CUI [2])
C0023474 (UMLS CUI [3])
prior therapy
Item
patients receiving prior bmt are eligible. if myeloablative chemoradiotherapy was used in the prior transplant patients must be >90 days from transplant. if non-myeloablative therapy was used patients must be >30 days post-transplant.
boolean
C0005961 (UMLS CUI [1])
C0436307 (UMLS CUI [2])
C0436307 (UMLS CUI [2])
CD33 expression
Item
leukemia cells must express cell surface cd33 evaluated by flow cytometry in > 20% of leukemia cells.
boolean
C0054952 (UMLS CUI [1])
donor for bone marrow or stem cell transplant
Item
patients must have an hla-compatible related donor (6/6 or 5/6 hla-match) capable of donating bone marrow or g-csf stimulated peripheral blood stem cells using aphereses techniques or a 6/6 hla matched unrelated bone marrow donor (serologic matching for class i, molecular matching for dr?1).
boolean
C0013018 (UMLS CUI [1])
ecog and laboratory values
Item
patients must have a ecog ps<2 (appendix 6), cr<2.0, bilirubin <2, and (sgpt) <3x normal
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C1520224 (UMLS CUI [4])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C1520224 (UMLS CUI [4])
life expectancy
Item
patients must have an estimated life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
informed consent
Item
patient and donor must sign informed consent. unrelated donors will be consented according to the national donor marrow registry policy
boolean
C0021430 (UMLS CUI [1])
infection
Item
uncontrolled active infection
boolean
C0009450 (UMLS CUI [1])
hiv
Item
hiv disease
boolean
C0019682 (UMLS CUI [1])
pregnancy and lactation
Item
pregnancy and nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
cns leukemia
Item
active, uncontrolled cns leukemia
boolean
C1332884 (UMLS CUI [1])